Gujasit 15/100mg Tablet
₨ 627
About this product
Overview
Gujasit 15/100mg Tablet is a combination medication used for the management of type 2 diabetes mellitus. It contains two active ingredients: Ertugliflozin & Sitagliptin. This combination provides complementary mechanisms of action to help lower blood sugar levels and improve glycemic control.
Key Ingredients
- Ertugliflozin: Ertugliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels.
- Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the amount of glucose produced by the liver.
Uses
- Type 2 Diabetes Management: Gujasit 15/100mg Tablet is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. The combination of Ertugliflozin and Sitagliptin helps lower blood sugar levels through complementary mechanisms of action.
Administration
- Gujasit 15/100mg Tablet is typically taken orally, once daily, with or without food, as directed by a healthcare professional.
- The dosage may vary depending on individual patient factors such as kidney function, response to treatment, and other medications being taken for diabetes management.
- It is crucial to follow the prescribed regimen provided by the healthcare provider to achieve optimal glycemic control and reduce the risk of complications associated with diabetes.
Precautions
- Before starting treatment with Gujasit 15/100mg Tablet, inform your healthcare provider about any existing medical conditions, especially kidney problems or a history of diabetic ketoacidosis.
- Inform your healthcare provider about all medications, supplements, and herbal products you are currently taking, as they may interact with Ertugliflozin and Sitagliptin.
- Monitor blood sugar levels regularly as directed by your healthcare provider while taking Gujasit 15/100mg Tablet to ensure effective glycemic control.
- Report any signs of adverse effects such as urinary tract infections, genital yeast infections, or symptoms of hypoglycemia (low blood sugar) to your healthcare provider promptly.
Gujasit 15/100mg Tablet, containing a combination of Ertugliflozin and Sitagliptin, offers a comprehensive approach to managing type 2 diabetes mellitus. By targeting multiple pathways involved in glucose regulation, it helps lower blood sugar levels and improve overall glycemic control.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.